by Jessica Casebolt | Jul 17, 2024 | Providers, Tea Leaves
Telehealth advocates welcomed the Centers for Medicare and Medicaid Services’ (CMS) proposed 2025 Medicare physician fee schedule, which extends key telehealth flexibilities introduced during the COVID-19 pandemic. The proposed rule includes permanent allowances...
by Jessica Casebolt | Jul 17, 2024 | Life Sciences, Tea Leaves
Pfizer has unveiled plans to develop an oral daily medication for weight loss, similar to existing treatments like Ozempic and Zepbound. The pharmaceutical giant reported positive results from clinical trials of its oral GLP-1 agonist candidate danuglipron, indicating...
by Jessica Casebolt | Jul 17, 2024 | M&A, Tea Leaves
The House Appropriations Committee approved the fiscal 2025 HHS spending plan along party lines despite Democratic objections to Republican initiatives aimed at restricting abortion access and restructuring National Institues of Health (NIH). The GOP-proposed budget...
by Jessica Casebolt | Jul 17, 2024 | Providers, Tea Leaves
The Centers for Medicare and Medicaid Services (CMS) has proposed a 2.6 percent reimbursement increase for hospital outpatient departments and ambulatory surgical centers next year, reflecting a projected 3 percent market basket increase offset by a -0.4 percent...
by Jessica Casebolt | Jul 17, 2024 | Payers, Tea Leaves
The Federal Trade Commission (FTC) is poised to sue the three largest pharmacy benefit managers (PBMs) in the United States — CVS’ Caremark, Cigna’s Express Scripts, and UnitedHealth’s Optum Rx — over their pricing negotiations with pharmaceutical...
Recent Comments